Introduction and definitions | p. 3 |
Receptors and concentration-response relationships | p. 9 |
Absorption, distribution, metabolism, and elimination | p. 27 |
Clinical pharmacokinetics and issues in therapeutics | p. 41 |
Gene therapy and emerging molecular therapies | p. 57 |
Regulated drug development and usage | p. 71 |
Herbals and natural products | p. 77 |
Introduction to the autonomic nervous system | p. 89 |
Drugs affecting the parasympathetic nervous system and autonomic ganglia | p. 103 |
Drugs affecting the sympathetic nervous system | p. 119 |
Regulation of blood pressure by the autonomic nervous system | p. 141 |
Antihypertensive drugs | p. 149 |
Diuretics : drugs that increase the excretion of water and electrolytes | p. 163 |
Antiarrhythmic drugs | p. 183 |
Drugs to treat heart failure | p. 199 |
Vasodilators and nitric oxide synthase | p. 217 |
Prostaglandins and related autacoids | p. 227 |
Lipid-lowering drugs and atherosclerosis | p. 235 |
Drugs to treat blood disorders | p. 251 |
Introduction to the central nervous system | p. 265 |
Treatment of Parkinson's and Alzheimer's diseases | p. 277 |
Treatment of psychotic disorders | p. 285 |
Treatment of affective disorders | p. 293 |
Treatment of anxiety and sleep disorders | p. 305 |
Ethanol and related compounds | p. 315 |
Treatment of eating disorders and obesity | p. 325 |
Treatment of seizure disorders | p. 331 |
General anesthetics | p. 341 |
Skeletal muscle relaxants | p. 355 |
Local anesthetics | p. 365 |
Drugs to control pain | p. 373 |
Drug and substance abuse | p. 393 |
Glucocorticoids and mineralocorticoids | p. 409 |
Drugs to treat asthma and chronic obstructive pulmonary disease | p. 423 |
Estrogens and progestins | p. 435 |
Androgens and antiandrogens | p. 453 |
Thyroid and antithyroid drugs | p. 465 |
Insulin and drugs used in the therapy of diabetes mellitus | p. 473 |
Drugs affecting uterine motility | p. 489 |
Hypothalamic-pituitary hormones | p. 499 |
Calcium-regulating hormones and other agents affecting bone | p. 511 |
Mechanisms of action of antineoplastic drugs | p. 523 |
Clinical effects of antineoplastic drugs | p. 543 |
Principles of antimicrobial use | p. 551 |
Bacterial cell wall inhibitors | p. 567 |
Inhibitors of bacterial ribosomal actions | p. 585 |
Bacterial folate antagonists, fluoroquinolones, and other antibacterial agents | p. 607 |
Selection of an antibacterial agent | p. 619 |
Antimycobacterial agents | p. 625 |
Antifungal agents | p. 639 |
Antiviral agents | p. 651 |
Drugs to treat parasitic infections | p. 665 |
Immunopharmacology | p. 681 |
Histamines and antihistamines | p. 701 |
Gastrointestinal drugs | p. 711 |
Toxicology | p. 725 |
Table of Contents provided by Blackwell. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.